4594 — BrightPath Biotherapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥4bn
- ¥3bn
- ¥0m
Annual cashflow statement for BrightPath Biotherapeutics Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,860 | -1,717 | -1,482 | -1,484 | -1,166 |
| Depreciation | |||||
| Non-Cash Items | 47.6 | -32.7 | -0.275 | 12.2 | 10.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -34.7 | -86.6 | -65.1 | 250 | -1.19 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,784 | -1,770 | -1,512 | -1,204 | -1,157 |
| Capital Expenditures | -110 | -35.3 | -17.6 | -1.76 | -7.65 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3.25 | -0.937 | 0.08 | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -107 | -36.2 | -17.6 | -1.76 | -7.65 |
| Financing Cash Flow Items | -2.23 | — | — | — | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.52 | 2,053 | 569 | 432 | 691 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,883 | 247 | -960 | -774 | -474 |